(3/3) …historical controls. This makes us even more optimistic that AIVITA’s second-generation DC-ATA product, which utilizes antigens from autologous GBM tumor-initiating cells that are self-renewing in cell culture, will yield positive results in our randomized Phase 3 trial.

(2/3) Despite their negative Ph 3 trial, we are happy to see that their first-generation dendritic cell vaccine loaded with antigen from whole autologous tumor cells was associated with prolonged survival in a subset of GBM patients when compared with a particular subset of…

(1/3) Autologous dendritic cells loaded with autologous tumor antigens (DC-ATA) is a promising approach for therapeutic anti-cancer vaccines. We have noted the recent 11/17 announcement and related publications by Northwest Bio. …

@NatureNews Science is under attack by the Trump Admin. There are several good Dem candidates w/ science backgrounds running for Congress in 2018 DrWestinForTX07 @JessPhoenix2018 @DocTran2018 Dr. Hans Keirstead It’s time to put them front & center. #IBelieveInScience

BREAKING NEWS: Moscow is not part of CA48 if you vote for Hans Kirstead x.com/drhanskeirstea…

Hey, Orange County--put some education and science into your representation. Vote for Dr. Hans Keirstead x.com/drhanskeirstea…